author-photo

Magdalena Klanova

First Faculty of Medicine, Charles University in Prague
Charles University in Prague

33

Papers

273

Citations

Citation Trend

Filter By

Papers (22) Sort By

Journal Conference Others

Drug Resistance in Non-Hodgkin Lymphomas.

2020 International Journal of Molecular Sciences
- Pavel Klener
- Magdalena Klanova
Show All
- Source
- Cite
- Save
Citations (14)
BCL-2 Proteins in Pathogenesis and Therapy of B-Cell Non-Hodgkin Lymphomas.

2020 Cancers
- Magdalena Klanova
- Pavel Klener
Show All
- Source
- Cite
- Save
Citations (21)
CD31/PECAM-1 impacts engraftment, growth and spread of mantle cell lymphoma cells and positively correlates with extramedullary involvement

2020 Leukemia & Lymphoma
Show All
- Source
- Cite
- Save
Citations (1)
Co-targeting of BCL2 with venetoclax and MCL1 with S63845 is synthetically lethal in vivo in relapsed mantle cell lymphoma

2019 Clinical Cancer Research
Show All
- Source
- Cite
- Save
Citations (37)
Role of Angiogenesis and Anti-Angiogenic Treatment Strategies in Mantle Cell Lymphoma

2018 Blood
Show All
- Source
- Cite
- Save
Citations (0)
Co-Targeting of BCL2 with Venetoclax and MCL1 with S63845 Is Synthetically Lethal In Vivo in Relapsed Refractory Mantle Cell Lymphoma with Complex Karyotype Changes

2018 Blood
Show All
- Source
- Cite
- Save
Citations (0)
Systematic Analysis of the Prognostic Impact of Somatic Mutations in Diffuse Large B-Cell Lymphoma (DLBCL) with Evaluation of Cell-of-Origin Dependence: Results from the Phase 3 GOYA Trial in Previously Untreated DLBCL

2017 Blood
Show All
- Source
- Cite
- Save
Citations (1)
DOUBLE-EXPRESSOR LYMPHOMAS DO NOT HAVE INFERIOR OUTCOME AFTER AUTOLOGOUS STEM-CELL TRANSPLANT IN THE FIRST LINE TREATMENT

2017 Hematological Oncology
Show All
- Source
- Cite
- Save
Citations (0)
ESTABLISHED CELL LINES AND PATIENT-DERIVED XENOGRAFTS REPRESENT EQUALLY RELEVANT MODELS OF AGGRESSIVE LYMPHOMAS

2017 Hematological Oncology
Show All
- Source
- Cite
- Save
Citations (0)
Low Peripheral Blood NK Cell Count Is Associated with Worse Clinical Outcome in Patients with Follicular Lymphoma (FL) and Diffuse Large B-Cell Lymphoma (DLBCL) Treated with Immunochemotherapy: Results from the Frontline Phase 3 GALLIUM and GOYA Trials

2017 Blood
Show All
- Source
- Cite
- Save
Citations (2)